Pharmacological rescue of Ras signaling, GluA1-dependent synaptic plasticity, and learning deficits in a fragile X model.
Pharmacological rescue of Ras signaling, GluA1-dependent synaptic plasticity, and learning deficits in a fragile X model.
复制标题
DOI:
10.1101/gad.232470.113
复制
发表时间:
2014-02-01
影响因子:
10.5
通讯作者:
Zhu JJ
中科院分区:
文献类型:
--
作者:
Lim CS;Hoang ET;Viar KE;Stornetta RL;Scott MM;Zhu JJ
Fragile X syndrome, caused by the loss of Fmr1 gene function, is the most common form of inherited mental retardation. Lim et al. find that compounds activating serotonin (5HT) subtype 2B receptors or dopamine (DA) subtype 1-like receptors and those inhibiting 5HT2A-Rs or D2-Rs enhance Ras signaling, GluA1-dependent synaptic plasticity, and learning in Fmr1 knockout mice. Combining 5HT and DA compounds at low doses synergistically restored normal learning. This suggests that properly dosed and combined FDA-approved psychoactive drugs may effectively treat the cognitive impairment associated with fragile X syndrome. Fragile X syndrome, caused by the loss of Fmr1 gene function, is the most common form of inherited mental retardation, with no effective treatment. Using a tractable animal model, we investigated mechanisms of action of a few FDA-approved psychoactive drugs that modestly benefit the cognitive performance in fragile X patients. Here we report that compounds activating serotonin (5HT) subtype 2B receptors (5HT2B-Rs) or dopamine (DA) subtype 1-like receptors (D1-Rs) and/or those inhibiting 5HT2A-Rs or D2-Rs moderately enhance Ras–PI3K/PKB signaling input, GluA1-dependent synaptic plasticity, and learning in Fmr1 knockout mice. Unexpectedly, combinations of these 5HT and DA compounds at low doses synergistically stimulate Ras–PI3K/PKB signal transduction and GluA1-dependent synaptic plasticity and remarkably restore normal learning in Fmr1 knockout mice without causing anxiety-related side effects. These findings suggest that properly dosed and combined FDA-approved psychoactive drugs may effectively treat the cognitive impairment associated with fragile X syndrome.
登录
查看更多内容
影响因子:
7.7
作者:
Alejandra Rosales-Reynoso, Monica;Berenice Ochoa-Hernandez, Alejandra;Barros-Nunez, Patricio
通讯作者:
Barros-Nunez, Patricio
影响因子:
5.6
作者:
David, Denis J.;Wang, Jingwen;Hen, Rene
通讯作者:
Hen, Rene
DOI:
10.1523/jneurosci.0402-10.2010
发表时间:
2010-08-11
期刊:
The Journal of neuroscience : the official journal of the Society for Neuroscience
影响因子:
--
作者:
Gross C;Nakamoto M;Yao X;Chan CB;Yim SY;Ye K;Warren ST;Bassell GJ
通讯作者:
Bassell GJ
影响因子:
82.9
作者:
通讯作者:
--
影响因子:
25
作者:
Chen, X;Garelick, MG;Storm, DR
通讯作者:
Storm, DR